Sansure Biotech, Inc. engages in the research, development, production, and sales of diagnostic reagents and instruments. It also provides third-party medical testing services. The company's products include viral hepatitis, genital infection & genetics, pediatric infection, respiratory infection, nucleic acid blood screening, scientific research, public health, animal disease, nucleic acid extraction, and biochemical series reagents; automatic nucleic acid detection reaction system, and point-of-care testing mobile molecular diagnostic system series instrument; and fluorescence polymerase chain reaction assay software. Sansure Biotech was founded on April 23, 2008 and is headquartered in Changsha, China.